{
    "2018-06-29": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Abbvie, Androgel partner owe $488 million in antitrust case: U.S. judge",
                "features": {
                    "keywords": [
                        "Abbvie",
                        "Androgel",
                        "antitrust",
                        "partner",
                        "owe"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Lilly's (LLY) Taltz Positive in Ankylosing Spondylitis Study",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Taltz",
                        "Positive",
                        "Ankylosing",
                        "Spondylitis",
                        "Study"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-05-02",
                "original_text": "Vertex Pops As Rival Disappoints In Cystic Fibrosis And AbbVieOpts Out",
                "features": {
                    "keywords": [
                        "Vertex",
                        "Pops",
                        "Rival",
                        "Disappoints",
                        "Cystic",
                        "Fibrosis",
                        "AbbVie",
                        "Opts",
                        "Out"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-02",
                "original_text": "Vertex Pharma Jumps 14% After Rival Releases Poor Cystic Fibrosis Drug Results",
                "features": {
                    "keywords": [
                        "Vertex",
                        "Pharma",
                        "Jumps",
                        "Rival",
                        "Releases",
                        "Poor",
                        "Cystic",
                        "Fibrosis",
                        "Drug",
                        "Results"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-02",
                "original_text": "Why Vertex Pharmaceuticals Incorporated Stock Surged 14% Today",
                "features": {
                    "keywords": [
                        "Vertex",
                        "Pharmaceuticals",
                        "Stock",
                        "Surged"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-12",
                "original_text": "XLV, UNH, MRK, ABBV: Large Outflows Detected at ETF",
                "features": {
                    "keywords": [
                        "XLV",
                        "UNH",
                        "MRK",
                        "ABBV",
                        "Large",
                        "Outflows",
                        "ETF"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-05",
                "original_text": "Galapagos: Silver Lining to Disappointing Study Data",
                "features": {
                    "keywords": [
                        "Galapagos",
                        "Silver",
                        "Lining",
                        "Disappointing",
                        "Study",
                        "Data"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-10",
                "original_text": "Bad News Delivers a Decisive Blow to Galapagos N.V.",
                "features": {
                    "keywords": [
                        "Bad",
                        "News",
                        "Delivers",
                        "Decisive",
                        "Blow",
                        "Galapagos"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-15",
                "original_text": "Will a Trade War With China Wreak Havoc in US Healthcare?",
                "features": {
                    "keywords": [
                        "Trade",
                        "War",
                        "China",
                        "Wreak",
                        "Havoc",
                        "US",
                        "Healthcare"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-20",
                "original_text": "Should Value Investors Consider AbbVie (ABBV) Stock Now?",
                "features": {
                    "keywords": [
                        "Value",
                        "Investors",
                        "Consider",
                        "AbbVie",
                        "Stock"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-10",
                "original_text": "Benzinga's Daily Biotech Pulse: Gemphire On Fire, Acceleron-Celgene Taste Success, AbbVie Ditches Galapagos",
                "features": {
                    "keywords": [
                        "Benzinga",
                        "Daily",
                        "Biotech",
                        "Gemphire",
                        "Fire",
                        "Acceleron",
                        "Celgene",
                        "Success",
                        "AbbVie",
                        "Ditches",
                        "Galapagos"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-15",
                "original_text": "Biotech Stocks Facing FDA Decision In July",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Stocks",
                        "Facing",
                        "FDA",
                        "Decision",
                        "July"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}